ModivCare (ModivCare) Stock Based Compensation : $6 Mil (TTM As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is ModivCare Stock Based Compensation?

ModivCare's Stock Based Compensation for the three months ended in Dec. 2023 was $2 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was $6 Mil.

ModivCare Stock Based Compensation Historical Data

The historical data trend for ModivCare's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ModivCare Stock Based Compensation Chart

ModivCare Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Stock Based Compensation

Get a 7-Day Free Trial

5.41

3.93

5.90

6.87

6.46

ModivCare Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Stock Based Compensation	Get a 7-Day Free Trial															1.72	1.12	1.16	1.74	2.43

ModivCare Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $6 Mil.

ModivCare Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of ModivCare's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

ModivCare (ModivCare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ModivCare Inc (NAS:MODV) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

PRF0:Germany

Address

6900 Layton Avenue, 12th Floor, Denver, CO, USA, 80237

Website

https://www.modivcare.com

ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.

Executives

Barbara Gutierrez	officer: Chief Financial Officer	8950 E. LOWRY BLVD., DENVER CO 80230
L Heath Sampson	officer: Chief Financial Officer	C/O ADVANCED EMISSIONS SOLUTIONS, INC., 9135 S RIDGELINE BLVD STE 200, HIGHLANDS RANCH CO 80129
Coliseum Capital Management, Llc	director, 10 percent owner	105 ROWAYTON AVENUE, ROWAYTON CT 06853
Henry Toledo	officer: Chief People Officer	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Jessica Kral	officer: Chief Information Officer	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Anne E, Bailey	officer: President, Home Division	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Rebecca Orcutt	officer: VP, Chief Accounting Officer	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Brett M. Hickman	officer: Chief Commercial Officer	6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Ilias Simpson	officer: President, Transportation	6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Jason E Anderson	officer: President of ModivCare Home	6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Grover Wray	officer: Chief Human Resources Officer	DIGITALGLOBE, INC., 1300 WEST 120TH AVENUE, WESTMINSTER CO 80234
Daniel E Greenleaf	director, officer: CEO and President	C/O NABI BIO PHARMACEUTICALS, 5800 PARK OF COMMERCE BLVD., N.W., BOCA RATON FL 33487
Jonathan B Bush	officer: SVP, GC and Secretary	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Kenneth Shepard	officer: Vice President, CAO	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Stacy Saal	director	4700 SOUTH SYRACUSE STREET, 4TH FLOOR, DENVER CO 80237